Decentralized Clinical Trials
Flexible Trial Design, Centered on the Patient Experience
Optimized and integrated Decentralized Clinical Trials put the patient experience first
Decentralized clinical trials (DCTs) have reached mainstream adoption, yet they remain genuinely challenging for novel therapies targeting complex and rare diseases with narrowly defined patient populations, where logistical and data challenges can derail a study before it gets moving.
DCT is not technology. Veristat integrates remote monitoring, patient-reported outcomes, hybrid/virtual models, e-consent, and at-home nursing into one unified strategy, combining the best elements from traditional, hybrid, and fully decentralized trial methodologies across drug development, all guided by what the data says patients and sites actually need.
Solving Challenges with Customized DCT Solutions
Veristat offers flexible, customizable decentralized approaches where traditional on-site activities, dosing, lab work, ePRO collection, clinical assessments, medical history, safety visits, and follow-up, can be conducted remotely, at-home, or hybrid, including:
- Investigational product shipped directly to patients or delivered by traveling nurses
- At-home nursing visits for patient dosing
- Telemedicine consultations with investigators
- The customizations are infinite.
How to Make a Decentralized Trial Toolbox Work?
Successful virtual trials require integration beyond traveling nurses. Our full-service approach includes:
Digital Patient Recruitment/Retention Methodologies
- Digital marketing and branding strategies for recruitment/education
- Physician-staffed call center for patient qualification/registration
- Multi-channel communication coordination among sites, at-home nurses, patients, and vendors
At-Home Patient Visits
- Protocol-compliant nursing services conducting home visits
- Differentiated logistics (supplies shipped to patients vs. sites, lab facilitation)
- On-site source data collection
Virtual Patient Interactions
- Telemedicine connections between patients and treating physicians
- ePRO, eSource, and eConsent integrated with Electronic Data Capture (EDC)
- Remote monitoring for traditional and virtual sites
Why Veristat
Integrating DCT Solutions Into How We Run Clinical Trials
Limited patient availability is one of the biggest threats to a trial's timeline. Veristat's decentralized approach addresses it directly:
- Improves recruitment, inclusion, and retention by reducing travel burden
- Removes geographic barriers to patient eligibility
- Offers fully virtual, all on-site, or hybrid trial models
- Provides fully integrated, customized approaches that accommodate patient, site, and sponsor comfort levels
- Eliminates silos between sites, sponsors, and CROs through integrated trial conduct
- Increases accessibility to eligible patients with individualized approaches supporting greater diversity
NEXT STEPS
What's Next in the Drug Development Process
Monitoring & Site Management.
Ensure the sites recruiting and retaining your participants stay on track.
Strategic Consulting.
Build recruitment and retention planning into your broader development strategy from the start.
Clinical Operations.
Connect recruitment and retention efforts to the broader operational plan running your trial.
PROOF & RESOURCES
Learn More with These Resources
Data-Driven Strategies to Advance Development and Approval of Rare Disease Therapies
Download →
Four Pillars of Success in Neurology Trials
Download →
Addressing Drug Developer Challenges with Decentralized Clinical Trials
Listen Now →
Let's Talk.
We know there are always unknown challenges when bringing a novel therapeutic to market, so we've assembled an extraordinary team of scientific-minded experts who have mastered the complexities of therapeutic development, enabling sponsors to succeed in extending and saving lives.
Frequently Asked Questions
A decentralized clinical trial uses remote and virtual elements, such as at-home nursing visits, telemedicine, e-consent, and remote monitoring, to bring study activities to patients rather than requiring them to travel to a traditional trial site. DCTs can be fully virtual or a hybrid combination of on-site and remote components.
Not necessarily. A virtual trial is fully remote, while a decentralized trial can combine traditional, hybrid, and fully decentralized elements within a single study, adapting the model to what works best for the patient population, sites, and sponsor.